Transaction #676 · Form 4 · 0001731122-25-001384
Endovia Health Sciences, Inc. · Stock award · Stock Options (Right to Buy)
Endovia Health Sciences, Inc. · Transacted March 20, 2025 · Filed October 15, 2025
What does this filing report?
An SEC Form 4 filing for Endovia Health Sciences, Inc. records a stock award involving Stock Options (Right to Buy) on March 20, 2025. The reported quantity was 15,000. The filing date is October 15, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company CIK
- 0001553788
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 15,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 15,000
- Ownership description
- Not reported
- SEC acceptance time
- Oct 15, 2025, 4:16 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Devereux William T ↗
Chief Financial Officer
CIK 0002089296
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 15,000
- Conversion / exercise price
- 6.04
- Exercise date
- Not reported
- Expiration date
- March 20, 2030
Filing footnotes & remarks
- F1
- The stock options vest as follows: 5,000 are vested, 5,000 vest on March 20, 2026 and 5,000 vest on March 20, 2027, subject in each case to continued services to the Company as of each applicable vesting date.
- F2
- Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.